Serum Gamma Glutamyl Transferase Levels in Association with Lipids and Lipoproteins in Type 2 Diabetes Mellitus
Keywords:
Serum gamma glutamyl transferase, Lipids, Blood glucose, Type2 diabetes mellitusAbstract
Introduction: Serum gamma glutamyl transferase is widely used as a marker for alcohol induced liver disease. Recently it has gained importance due to its role in type2 diabetes mellitus. A raised serum gamma glutamyl transferase level indicates hepatic steatosis and visceral fat deposition, leading to insulin resistance and diabetes. In the present study we examined the association between serum gamma glutamyl transferase levels with lipids and lipoproteins in diabetes mellitus.
Methodology: The study was carried out on 50 subjects with type2 diabetes mellitus and compared with 50 ages and sex matched healthy controls attending outpatient department of General Medicine, Narayana medical college, Nellore. Serum gamma glutamyl transferase was measured by calorimetric kinetic assay. Fasting blood sugar was measured by glucose oxidase method using automated analyzer. Serum triglycerides, total cholesterol and high density lipoprotein are measured by standard enzymatic procedures and low density lipoprotein by friedwald equation.
Results: Serum gamma glutamyl transferase levels in diabetic cases were significantly elevated compared to normal healthy controls [p <0.001]. There was a positive correlation between gamma glutamyl transferase, lipids and low density lipoprotein and inverse correlation with high density lipoprotein (r=-0.298)].
Conclusion: Our results suggest a possible role of gamma glutamyl transferase in the pathophysiology and progression of type2 diabetes mellitus.
References
1. André.P. Balkau.B. Charles.M.A. & Eschwège.E. Gamma-glutamyl transferase activity and development of the met-abolic syndrome, in middle-aged men and women: the DESIR cohort. Diabetes Care 2007: 30(9):2355-61. PMID: 17586745 [PubMed - indexed for MEDLINE]
2. Whitfield.J.B. Gamma glutamyl transferase. Critical reviews in clinical laboratory sciences 2000; 138(4): 263-355.
3. Benini, F, Pigozzi, M. G., Baisini, O.Romanini, L.Ahmed, H. Pozzi and Lanzini A. Increased serum gam-ma‐glutamyl‐transpeptidase concentration is associated with nonalcoholic steatosis and not with cholestasis in pa-tients with chronic hepatitis C. Journal of gastroenterology and hepatology. 2007; 22(10), 1621-1626.
4. Huseby,N.E. Hydrophilic form of γ-glutamyltransferase: pro-teolytic formation in liver homogenates and its estimation in serum. Clinica Chimica Acta. 1982; 124(1), 113-121.
5. Grundy, Scott M. Gamma-glutamyl transferase another bi-omarker for metabolic syndrome and cardiovascular risk. Arteriosclerosis, Thrombosis, and Vascular Biology . 2007;27(1) : 4-7.
6. Sabanayagam, C.Shankar, A.Li, J.Pollard, & Ducatman, A. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. European journal of epidemiolo-gy. 2009; 24(7): 369-373.
7. Lim, J. S.Lee, D.H.Park, J.Y.Jin, & Jacobs. A strong interac-tion between serum γ-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the third national health and nutrition examination survey. Clinical chemistry. 2007; 53(6), 1092-1098.
8. Duckworth, William C., Frederick G. Hamel, and Daniel E. Peavy. Hepatic metabolism of insulin. The American jour-nal of medicine. 1988; 85.5 : 71-76.
9. KasapogluB. Turkay.C. Bayram.Y & Koca.C. Role of GGT in diagnosis of metabolic syndrome: A clinic-based cross-sectional survey. Indian Journal of Medical Research. 2010;132(1):56-61.
10. Lippi G, Targher G, Montagnana M, Salvagno GL, Guidi GC.Relationship between gamma-glutamyltransferase, li-pids and lipoprotein(a) in the general population. Clin Chim Acta 2007; 384: 163-166.
11. Vozarova B, Stefen N, Lindsey RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002; 51. 1889-1895.
12. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascularrisk factor changes in Finland 1972-1997. Int.J Epidemiol. 200; 29: 49-56.
13. Koro, C. E., Bowlin, S. J., Bourgeois, N., & Fedder, D. O.. Glycemic control from 1988 to 2000 among US adults di-agnosed with type 2 diabetes a preliminary re-port. Diabetes Care, 2004; 27(1), 17-20.
14. Lee, Duk-Hee, Myron D. Gross, and David R. Jacobs. Asso-ciation of serum carotenoids and tocopherols with γ-glutamyltransferase: the Cardiovascular Risk Development in Young Adults (CARDIA) Study.Clinical chemistry.2004; 50.3 : 582-588.
15. Duk-Hee Leea, Rune Blomhoffb and David R. Jacobs Jr. "Is serum gamma glutamyltransferase a marker of oxidative stress?" Free radical research . 2004;38.6: 535–539.
16. Sabanayagam C, Shankar A, LiJ, Pollard C, Ducatman A. Serum gamma-glutamyl transferase level and diabetes mellitus among US adults. Eur. jou.Epidemiol.2009;24:369-73.
17. Iqbal, Azhar, Uzma Iftikhar, Farah Amir Ali, Shakoor Memon, and Nudrat Zuberi. Comparison of gamma glu-tamyltransferase in normal and in type 2 diabetics. JPMA-Journal of the Pakistan Medical Associa-tion.2010: 60:11,945-948
18. Giovanni Targher,Lorenz Bertolini1,Felice Poli,Stefano Rodella,Luca ala1 et al.Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients. Diabetes . 2005; 54( 12): 3541-3546.
Downloads
Published
How to Cite
Issue
Section
License
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
